Rheumatology Drug Review: For Boards and Clinical Practice
Paperback – January 18, 2020
Description :
Chapter 1: DMARDsChapter 2: ImmunomodulatorsChapter 3: JAK inhibitorsChapter 4: BiologicsChapter 5: Biosimilars - What the Rheumatologist Should KnowChapter 6: Gout medicationsChapter 7:
GlucocorticoidsChapter 8: NSAIDsChapter 9: Osteoporosis medicationsChapter 10: Investigational drugs